MHC class II regulation of CD8+T cell tolerance and implications in autoimmunity and cancer immunotherapy
Xiaojuan Zhou,Xian Jia,Zhe Huang,Chao Yang,Jiali Li,Wangnan Xie,Xiaoyu He,Wei Ying,Chenfeng Liu,Yun Liu,Kunyu Liao,Yazhen Hong,Xiao Lei Chen,Tianying Zhang,Ningshao Xia,Wen-Hsien Liu,Guo Fu,Changchun Xiao
DOI: https://doi.org/10.1016/j.celrep.2023.113452
IF: 8.8
2023-01-01
Cell Reports
Abstract:Major histocompatibility complex (MHC) class II-reactive CD8+ T cells are found in humans and animals, but little is known about their identity, development, and function. In this study, we discover a group of CD8+ T cells reactive to both MHC class I and II molecules in MHC class II-deficient mice. We clone their T cell re-ceptors (TCRs) and analyze their development and function. In wild-type animals, thymocytes bearing those TCRs are purged by negative selection. In the absence of MHC class II, they develop into mature CD8+ T cells. When encountering MHC class II in the periphery, they undergo robust activation and proliferation, attack self-tissues, and cause lethal autoimmune diseases. In adoptive T cell therapy, those CD8+ T cells are able to efficiently control MHC class II-expressing tumors. This study opens the door to investigation of dual -reac-tive CD8+ T cells, their development and selection in the thymus, and the perils and promises when their normal development and selection are compromised.